HCV Entry Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HCV Entry Inhibitor, covering 2018-04-18 to 2018-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection [Phase 1]